USBC, Inc. — Director's Dealing 2022

Dec 19, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: KNOW LABS, INC. (KNWN)
CIK: 0001074828
Period of Report: 2022-12-14

Reporting Person: Bosua Phillip (Director, CEO and President, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-14	Option to Purchase Common Stock	$1.41	A	1250000	Acquired	2027-12-14	Common Stock (1250000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3005000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to Purchase Common Stock	$1.28	2023-08-01	Common Stock (1000000)	1000000	Direct
Option to Purchase Common Stock	$1.10	2024-11-04	Common Stock (1200000)	1200000	Direct
Option to Purchase Common Stock	$1.53	2025-12-15	Common Stock (4264395)	4264395	Direct
Option to Purchase Common Stock	$2.09	2026-12-15	Common Stock (1300000)	1300000	Direct

Footnotes

F1: Option shares vest 25% quarterly over four years beginning 08/01/2018.

F2: Option shares vest upon approval of the Company's blood glucose measurement technology by the U.S. Food and Drug Administration.

F3: Milestone-based Option shares vest upon the Company's successful milestone achievements set forth in two Stock Option Agreements dated 12/15/2020.

F4: Options vest quarterly over four years. Immediate vesting upon the occurrence of a Change-in-Control.